Laser Prostate Centers of America Joins Forces with Francisco Gelpi, M.D., M.P.H. of Houston Metro Urology
HOUSTON, May 10, 2017 /PRNewswire/ -- Laser Prostate Centers of America (LPCA) announces that Francisco Gelpi, M.D., M.P.H. of Houston Metro Urology has joined forces with LPCA to bring comprehensive care to patients suffering from prostate cancer. Dr. Gelpi received his Master's in Public Health from Harvard University in Boston where he also did his fellowship in Urologic Oncology. Prior to this, he completed his internship and residency at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania where he was Chief Urology Resident. Dr. Gelpi is actively involved in numerous organizations in the field including the American Urological Association and his work on new treatment options for prostate cancer has been published in medical journals. Dr. Gelpi's dedication to the field along with his expertise, make him a great asset to the LPCA team. "I am very excited to collaborate with LPCA and further educate patients on prostate cancer treatment while providing the best possible individualized care to each patient," commented Dr. Gelpi.
Laser Prostate Centers of America has a multidisciplinary team of urologists and radiologists who evaluate each patient and discuss potential treatment options including focal laser ablation (FLA). The multidisciplinary approach allows patients to fully understand their diagnosis and treatment options to make more educated and informed decisions regarding their care.
Founded to help educate, diagnose, and treat men suffering from prostate cancer, LPCA offers the latest in diagnostics and image-guided treatments. Low grade prostate cancer treatment has long included active surveillance and more aggressive treatments such as radical prostatectomy and radiation. LPCA provides another option: focal treatment. Focal laser ablation for prostate cancer has advantages over traditional treatment. Not only is it a quick, minimally-invasive procedure, FLA is designed to target the cancerous area without damaging the entire prostate gland. The reduced risk of side effects including incontinence and impotence is a huge advantage of the treatment.
About Laser Prostate Centers of America (LPCA)
Laser Prostate Centers of America partners with a multi-specialty team of highly-skilled physicians trained in interventional radiology and urology to offer patients an alternative to traditional treatment and therapies with highly-advanced, minimally-invasive MRI-guided procedures. LPCA is a catalyst in bringing the most-advanced and appropriate diagnosis and treatment for patients with prostate cancer to the forefront.
Media Contact
Laser Prostate Centers of America
Nisha Franklin
888-502-5722
[email protected]
SOURCE Laser Prostate Centers of America
Share this article